Literature DB >> 11161080

Angiotensin converting enzyme inhibitor induced hyperkalaemic paralysis.

D Dutta1, M Fischler, A McClung.   

Abstract

Secondary hyperkalaemic paralysis is a rare condition often mimicking the Guillain-Barré syndrome. There have been a few case reports of hyperkalaemia caused by renal failure, trauma, and drugs where the presentation has been with muscle weakness. A case of hyperkalaemic paralysis caused by an angiotensin converting enzyme inhibitor is reported.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11161080      PMCID： PMC1741920          DOI： 10.1136/pmj.77.904.114

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  6 in total

1.  From ileostomy to sudden quadriplegia with electrocardiographic abnormalities: a short and unfortunate path.

Authors:  Manuel Delgado-Alvarado; Enrique Palacio-Portilla; Ana L Pelayo-Negro; Piedad Lerena; José Berciano
Journal:  Neurol Sci       Date:  2012-10-13       Impact factor: 3.307

2.  Hyperkalemia: A rare cause of acute flaccid quadriparesis.

Authors:  Suneel Kumar Garg; Sanjay Saxena; Deven Juneja; Omender Singh; Mukesh Kumar; Joy Dev Mukherji
Journal:  Indian J Crit Care Med       Date:  2014-01

3.  Reversible electrophysiological abnormalities in acute secondary hyperkalemic paralysis.

Authors:  Karkal R Naik; Aralikatte O Saroja; Mallikarjun S Khanpet
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

4.  Post-operative hyperkalaemic paralysis.

Authors:  G C Beattie; G V McDonnell; A J Wilkinson; R J Maxwell
Journal:  Ulster Med J       Date:  2003-05

5.  Acute ascending muscle weakness secondary to medication-induced hyperkalemia.

Authors:  Lauren A Kimmons; Justin B Usery
Journal:  Case Rep Med       Date:  2014-03-23

6.  Acute Ascending Flaccid Paralysis Secondary to Multiple Trigger Factor Induced Hyperkalemia.

Authors:  K H D Thilini Hemachandra; M B Kavinda Chandimal Dayasiri; Thamara Kannangara
Journal:  Case Rep Neurol Med       Date:  2018-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.